chr17-43125443-A-C
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000356906.8(NBR2):n.24A>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 210,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: not found (cov: 32) 
 Exomes 𝑓:  0.000014   (  0   hom.  ) 
Consequence
 NBR2
ENST00000356906.8 non_coding_transcript_exon
ENST00000356906.8 non_coding_transcript_exon
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.326  
Publications
3 publications found 
Genes affected
 NBR2  (HGNC:20691):  (neighbor of BRCA1 lncRNA 2) This gene was identified by its close proximity on chromosome 17 to tumor suppressor gene BRCA1. Experimental evidence indicates that the two genes share a bi-directional promoter. Transcription for either gene is controlled individually by distinct transcriptional repressor factors. A short (112 amino acid) open reading frame is observed which includes a region derived from a LINE1 element. A strong Kozak signal is not observed for the putative ORF and the stop codon is more than 55 nucleotides upstream of the last splice site for the transcript, suggesting that the transcript is subject to nonsense-mediated decay. Therefore, this gene does not appear to encode a protein. Glucose starvation induces the expression of this gene and the long non-coding RNA transcribed by it functions with AMP-activated protein kinase in mediating the energy stress response. [provided by RefSeq, Aug 2016] 
 BRCA1  (HGNC:1100):  (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020] 
BRCA1 Gene-Disease associations (from GenCC):
- breast-ovarian cancer, familial, susceptibility to, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
 - Fanconi anemia, complementation group SInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
 - pancreatic cancer, susceptibility to, 4Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
 - hereditary breast ovarian cancer syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79). 
BP6
Variant 17-43125443-A-C is Benign according to our data. Variant chr17-43125443-A-C is described in ClinVar as Likely_benign. ClinVar VariationId is 803424.Status of the report is criteria_provided_single_submitter, 1 stars. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD3 genomes 
Cov.: 
32
GnomAD4 exome  AF:  0.0000143  AC: 3AN: 210418Hom.:  0  Cov.: 0 AF XY:  0.0000172  AC XY: 2AN XY: 116148 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
3
AN: 
210418
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
2
AN XY: 
116148
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
5558
American (AMR) 
 AF: 
AC: 
0
AN: 
13614
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
5056
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
8216
South Asian (SAS) 
 AF: 
AC: 
2
AN: 
44830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
9006
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
700
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
113480
Other (OTH) 
 AF: 
AC: 
1
AN: 
9958
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.592 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
GnomAD4 genome  Cov.: 32 
GnomAD4 genome 
Cov.: 
32
Alfa 
 AF: 
Hom.: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Breast-ovarian cancer, familial, susceptibility to, 1    Benign:1 
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.